Literature DB >> 27527716

Short- and Long-Term Outcomes of Larynx-Preserving Surgery for Cervical Esophageal Cancer: Analysis of 100 Consecutive Cases.

Tomoki Makino1, Makoto Yamasaki2, Yasuhiro Miyazaki2, Tsuyoshi Takahashi2, Yukinori Kurokawa2, Kiyokazu Nakajima2, Shuji Takiguchi2, Masaki Mori2, Yuichiro Doki2.   

Abstract

BACKGROUND: Surgical interventions for cervical esophageal cancer (CEC), particularly larynx-preserving procedures, have not yet been standardized in terms of short- and long-term outcome.
METHODS: We retrospectively analyzed 100 consecutive surgeries for CEC in our department. We compared clinicopathological parameters and long-term outcomes between larynx-preserving esophagectomies (LP group) and nonpreserving procedures (NP group). We also evaluated preoperative predictive parameters for larynx-preservation.
RESULTS: Compared with the NP group, the LP group had significantly lower cT (P < 0.001) and cStage (P = 0.001) and shorter tumor length (P = 0.0108). Multivariate logistic regression analysis identified early cT stage, early cStage, and response to preoperative treatment as significant predictive parameters of larynx preservation. Larynx-preserving procedures could be performed for 90.5 % of T1-2 tumors regardless of preoperative treatment response. In contrast in T3-4 tumors, most nonresponders (92.3 %) were ineligible for larynx-preservation (P = 0.0012), whereas 54.3 % of responders could achieve larynx preservation. The average shortening of upward extension in T3-4 tumors after preoperative treatment was 20.0 mm in the LP group vs. 10.2 mm in the NP group (P = 0.051). The two groups were similar in terms of overall morbidity (including pneumonia), mortality, and postoperative hospital days. Importantly, larynx preservation for CEC neither worsened patient prognosis nor increased locoregional recurrence compared to the NP group.
CONCLUSIONS: Larynx-preserving esophagectomy for CEC is feasible and oncologically acceptable. The cT, cStage, and clinical response to preoperative treatment are important preoperative predictors of a patient's suitability for larynx-preservation.

Entities:  

Mesh:

Year:  2016        PMID: 27527716     DOI: 10.1245/s10434-016-5511-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Oncological outcomes of cervical esophageal cancer treated primarily with surgery: a systematic review and meta-analysis.

Authors:  Armando De Virgilio; Andrea Costantino; Carlo Castoro; Giuseppe Spriano; Bianca Maria Festa; Giuseppe Mercante; Davide Franceschini; Ciro Franzese; Marta Scorsetti; Andrea Marrari; Raffaele Cavina; Salvatore Marano
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-15       Impact factor: 3.236

2.  ASO Author Reflections: Peritumoral Lymphatic Vessels as a Predictor of Response to Chemotherapy and Survival in Esophageal Cancer.

Authors:  Tomoki Makino; Takeo Hara; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2020-04-20       Impact factor: 5.344

3.  Peritumoral Lymphatic Vessels Associated with Resistance to Neoadjuvant Chemotherapy and Unfavorable Survival in Esophageal Cancer.

Authors:  Takeo Hara; Tomoki Makino; Makoto Yamasaki; Koji Tanaka; Kotaro Yamashita; Yuya Nogi; Takuro Saito; Tsuyoshi Takahashi; Yukinori Kurokawa; Mitsuaki Tatsumi; Kiyokazu Nakajima; Eiichi Morii; Hidetoshi Eguchi; Yuichiro Doki
Journal:  Ann Surg Oncol       Date:  2020-04-23       Impact factor: 5.344

4.  Clinicopathological features and surgical treatment of cervical oesophageal cancer.

Authors:  Shao-Bin Chen; Xi-Hong Yang; Hong-Rui Weng; Di-Tian Liu; Hua Li; Yu-Ping Chen
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

5.  Manifestation of Urinary Tract Injury during Cervical Cancer Surgery Based on CT Urography Secretion Phase Images.

Authors:  Song Lin; Xiaoshan Li; Yan Zhang; Xiaowen Mao; Xingchi Liang; Shigang Cheng; Lingli Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-06-15       Impact factor: 3.009

6.  Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes.

Authors:  Peinan Chen; Xueke Zhao; Fuyou Zhou; Xin Song; Shoujia Hu; Yan Jin; Xianzeng Wang; Xuena Han; Zongmin Fan; Ran Wang; Bei Li; Wenli Han; Panpan Wang; Jilin Li; Lixin Wan; Liguo Zhang; Qide Bao; Fubao Chang; Yanru Qin; Zhiwei Chang; Jianwei Ku; Haijun Yang; Ling Yuan; Jingli Ren; Xuemin Li; Lidong Wang
Journal:  Cancer Biol Med       Date:  2020-02-15       Impact factor: 4.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.